At AstraZeneca, every one of our employees makes a difference to patient lives every day. Each and every one of us believes that science has the ability to change lives and that to deliver this takes many people with many skill sets. When we deliver a life-changing medicine, that success comes from the combined efforts of all of our people.
The Director, Payor Evidence role sits within the Payor Evidence function of the United States (US) Medical organization within Medical Biopharmaceuticals. This is a key role supporting Payor and is responsible for scientific and analytical input into Innovative Value Strategies (IVS) along with observational research strategies in support of payor interactions for AZ products (including cardiovascular, metabolic, renal and respiratory areas).
The activities focus on the strategy for the generation of evidence to assist payer decision-makers and include scientific evidence for innovative contracting strategies, reimbursement dossiers assets to support payor discussions.This role leads the internal and external communication of the clinical and economic value proposition and of scientific results to achieve maximal scientific impact and commercial success of AZ products throughout their life cycle.This position requires an experienced individual with expert scientific knowledge of health economics and outcomes research, innovative value strategies, its application throughout development process, strong business acumen, and excellent interpersonal skills.
Lead the development of the critical evidence generation strategy to support articulation of product clinical and economic value.
Lead US input into payer-related evidence plan as part of a core member of Core Values Team (CVT)
Develop scientific and data driven approach to support IVS (i.e. various types of payor contracting strategies)
Proactively and independently, contribute to research planning process and resolution of complex issues, especially if they affect market access decisions and evidence for product.
Represent Payor Evidence as member of the Core Medical Team (CMT).
Responsible for developing research strategies in response to value reviews of AZ products by external organizations, as appropriate and in alignment with current AZ approach.
Ensure US evidence strategy alignment with Therapeutic Area (TA) reimbursement, and regulatory strategies.
Serve as observational research expert within TA as it relates to all data evidence to support payor interactions.
Remain actively aware of the product environment by establishing, maintaining, and fostering internal (cross-functional, within the US and Global organizations) and external interactions with scientific experts.
Develop strategy, study design, along with support protocol development, (e.g., retrospective database analyses, payer analytic tools, systematic reviews, network meta-analyses, budget impact models, cost effectiveness models) to support evidence needs as determined by CVT strategy
Collaboration with Field Medical Affairs teams to compile evidence required to satisfy payer requirements, as necessary in alignment with overall product CVT strategy
Collaboration with Medical Biopharmaceutical Evidence group to execute on research to support all types of payor needs
Integration of the US payer viewpoint into Global development and reimbursement strategies.
Identification and effective use of internal and external data sources and/or research to support payer reimbursement dossiers and payer value propositions.
Input for the preparation of reimbursement/formulary documents.
Maintain current and in-depth understanding of health economic and outcomes research analytical methodologies.
Education, Qualifications, Skills and Experience :
Masters degree in a relevant field (e.g., health economics, outcomes research, health services research, epidemiology, health policy or related fields)
Ten years of relevant experience (e.g., academia, consulting, and/or industry); a minimum of five years in the pharmaceutical/biotechnology/medical device industry
Real World Evidence and health economics and outcomes research and their application to pharmaceutical development within the US market.
Experience with IVS in US payor environment including "hands on" experience in various frameworks for value-based contracts.
Comprehensive understanding of the pharmaceutical industry and regulatory requirements.
Knowledge of the US healthcare system and its changing needs for health economic and payer analytic information.
Leadership skills and problem-solving capability as demonstrated by ability to evaluate threats and opportunities for Health Economics strategy and modify as appropriate.
Well-developed conceptual and integrative thinking with capability to access internal and external resources for advice.
Proactive application of therapeutic area and disease treatment knowledge
Able to implement projects, including engagement with key stakeholders, with high degree of autonomy
Excellent written and verbal communication skills
Ability to work collaboratively across multiple functional groups across countries and regions
Doctoral degree in relevant field preferred (e.g., Ph.D., Pharm.D., M.D.)